Table 3

Odds ratios (95% confidence intervals) for bladder cancer among regular users of NSAIDs, with adjustment for other drugs, and among exclusive users.

Drug use
Adjusted modela
Exclusive use modelb

Controls N(%)
Cases N(%)
OR (95%CI)c
Controls N(%)
Cases N(%)
OR (95%CI)c

All NSAIDs






Never
278 (61.0)
232 (63.4)
1.0 (reference)
249 (68.0)
211 (74.6)
1.0 (reference)
Ever
178 (39.0)
134 (36.6)
0.6 (0.4–0.9)
117 (32.0)
72 (25.4)
0.6 (0.4–0.9)
Duration of used






≤ 4 yrs
61 (13.4)
47 (12.8)
0.7 (0.4–1.1)
46 (12.6)
25 (8.8)
0.6 (0.4–1.1)
4–10 yrs
58 (12.7)
37 (10.1)
0.5 (0.3–0.8)
35 (9.6)
23 (8.1)
0.6 (0.3–1.1)
>10 yrs
59 (12.9)
50 (13.7)
0.7 (0.4–1.1)
36 (9.8)
24 (8.5)
0.6 (0.4–1.1)
P for linear trende


0.020


0.029
Aspirin






Never
333 (73.0)
263 (71.9)
1.0 (reference)
249(78.3)
211(84.4)
1.0 (reference)
Ever
123 (27.0)
103 (28.1)
0.6 (0.4–0.9)
69(21.7)
39(15.6)
0.5 (0.3–0.8)
Duration of used






≤ 4 yrs
43 (9.4)
32 (8.7)
0.5 (0.3–0.9)
27(8.5)
10(4.0)
0.4 (0.2–0.8)
4–9 yrs
41 (9.0)
24 (6.6)
0.3 (0.2–0.6)
21(6.6)
12(4.8)
0.5 (0.2–1.0)
>9 yrs
39 (8.6)
47 (12.8)
0.9 (0.5–1.5)
21(6.6)
17(6.8)
0.7 (0.4–1.4)
P for linear trende


0.114


0.038
Ibuprofen






Never
399 (87.5)
332 (90.7)
1.0 (reference)
257 (88.3)
214 (89.5)
1.0 (reference)
Ever
57 (12.5)
34 (9.3)
0.8 (0.5–1.2)
34 (11.7)
25 (10.5)
0.9 (0.5–1.6)
Duration of used






≤ 3 yrs
22 (4.8)
15 (4.1)
0.9 (0.5–1.9)
11 (3.8)
11 (4.6)
1.5 (0.6–3.7)
3–10 yrs
16 (3.5)
8 (2.2)
0.5 (0.2–1.3)
10 (3.4)
7 (2.9)
0.7 (0.3–2.0)
>10 yrs
19 (4.2)
11 (3.0)
0.8 (0.4–1.8)
13 (4.5)
7 (2.9)
0.7 (0.3–1.8)
P for linear trende


0.244


0.484

a Model adjusted by age, sex, number of cigarettes smoked per day, and use of other NSAIDs and analgesics

b Model adjusted by age, sex, and number of cigarettes smoked per day

c Excluded 3 subjects missing number of cigarettes smoked per day.

d Based on tertile of duration of use among controls. No NSAID use is referent.

e Tests for trend were performed by including a single term for categorical duration of NSAID use using non-users as the reference category.

Fortuny et al. BMC Urology 2007 7:13   doi:10.1186/1471-2490-7-13